Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Vivos Therapeutics, Inc. (NASDAQ: VVOS)
VVOS Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
43.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
114.80%
VVOS Stock Analysis
VVOS
PE Ratio:
VVOS
PEG Ratio:
Not Available
VVOS
Forward EPS Growth (12 month):
0.00%
VVOS
PS Ratio:
0.2
VVOS
PSG Ratio:
VVOS
Forward Revenue Growth (12 month):
50.30%
VVOS Articles
No data was found